NCT07409506 · RECRUITING

Assessment of Informal Support Provided by Caregivers at Different Stages of Alzheimer's Disease

This study is not testing a drug or treatment. Researchers in France are using a structured questionnaire to measure how much time and effort family caregivers spend supporting people with Alzheimer's at different stages of the disease. The goal is to understand how caregiver workload shifts as the disease progresses. The phase is unspecified, and this is an observational study, not a clinical intervention trial.

Eligibility criteria

Inclusion Criteria:
* Patients from Charpennes Hospital included in the MEM-AURA cohort
* Patients aged 60 years and older at inclusion
* Patients with dementia due to clinically probable Alzheimer's disease, regardless of stage
* Patients with a Mini-Mental State Evaluation (MMSE) score ≤ 26 at inclusion
* Patients accompanied by a caregiver at inclusion
Exclusion Criteria:
* - Patients or caregivers who have expressed their opposition to the study
* Patients living in institutions or nursing homes
* Patients protected by law (under legal protection, guardianship, or conservatorship)
Early termination Criteria :
- Patients or caregivers withdrawing their consent to participate during the study

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-02-13

View full record on ClinicalTrials.gov

All APOE4 clinical trials